These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 36346274

  • 1. Circulating microRNAs associated with gestational diabetes mellitus: useful biomarkers?
    Dinesen S, El-Faitarouni A, Dalgaard LT.
    J Endocrinol; 2023 Jan 01; 256(1):. PubMed ID: 36346274
    [Abstract] [Full Text] [Related]

  • 2. Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes.
    Wander PL, Boyko EJ, Hevner K, Parikh VJ, Tadesse MG, Sorensen TK, Williams MA, Enquobahrie DA.
    Diabetes Res Clin Pract; 2017 Oct 01; 132():1-9. PubMed ID: 28783527
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.
    Hromadnikova I, Kotlabova K, Krofta L.
    Int J Mol Sci; 2022 Sep 13; 23(18):. PubMed ID: 36142536
    [Abstract] [Full Text] [Related]

  • 4. The Predictive Value of miR-16, -29a and -134 for Early Identification of Gestational Diabetes: A Nested Analysis of the DALI Cohort.
    Sørensen AE, van Poppel MNM, Desoye G, Damm P, Simmons D, Jensen DM, Dalgaard LT, The DALI Core Investigator Group.
    Cells; 2021 Jan 15; 10(1):. PubMed ID: 33467738
    [Abstract] [Full Text] [Related]

  • 5. Decreased Expression of Circulating miR-20a-5p in South African Women with Gestational Diabetes Mellitus.
    Pheiffer C, Dias S, Rheeder P, Adam S.
    Mol Diagn Ther; 2018 Jun 15; 22(3):345-352. PubMed ID: 29556924
    [Abstract] [Full Text] [Related]

  • 6. Circulating microRNA as Biomarkers for Gestational Diabetes Mellitus-A Systematic Review and Meta-Analysis.
    Dinesen S, El-Faitarouni A, Frisk NLS, Sørensen AE, Dalgaard LT.
    Int J Mol Sci; 2023 Mar 24; 24(7):. PubMed ID: 37047159
    [Abstract] [Full Text] [Related]

  • 7. miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes Mellitus.
    Juchnicka I, Kuźmicki M, Niemira M, Bielska A, Sidorkiewicz I, Zbucka-Krętowska M, Krętowski AJ, Szamatowicz J.
    Front Endocrinol (Lausanne); 2022 Mar 24; 13():839344. PubMed ID: 35340328
    [Abstract] [Full Text] [Related]

  • 8. Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases.
    Hromadnikova I, Kotlabova K, Dvorakova L, Krofta L.
    Int J Mol Sci; 2020 Mar 31; 21(7):. PubMed ID: 32244558
    [Abstract] [Full Text] [Related]

  • 9. The Temporal Profile of Circulating miRNAs during Gestation in Overweight and Obese Women with or without Gestational Diabetes Mellitus.
    Sørensen AE, van Poppel MNM, Desoye G, Simmons D, Damm P, Jensen DM, Dalgaard LT, The Dali Core Investigator Group.
    Biomedicines; 2022 Feb 18; 10(2):. PubMed ID: 35203692
    [Abstract] [Full Text] [Related]

  • 10. Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis.
    Filardi T, Catanzaro G, Grieco GE, Splendiani E, Trocchianesi S, Santangelo C, Brunelli R, Guarino E, Sebastiani G, Dotta F, Morano S, Ferretti E.
    Int J Mol Sci; 2022 Apr 12; 23(8):. PubMed ID: 35457094
    [Abstract] [Full Text] [Related]

  • 11. Unhealthy Levels of Phthalates and Bisphenol A in Mexican Pregnant Women with Gestational Diabetes and Its Association to Altered Expression of miRNAs Involved with Metabolic Disease.
    Martínez-Ibarra A, Martínez-Razo LD, Vázquez-Martínez ER, Martínez-Cruz N, Flores-Ramírez R, García-Gómez E, López-López M, Ortega-González C, Camacho-Arroyo I, Cerbón M.
    Int J Mol Sci; 2019 Jul 07; 20(13):. PubMed ID: 31284700
    [Abstract] [Full Text] [Related]

  • 12. miRNA Profiles in Extracellular Vesicles From Serum Early in Pregnancies Complicated by Gestational Diabetes Mellitus.
    Gillet V, Ouellet A, Stepanov Y, Rodosthenous RS, Croft EK, Brennan K, Abdelouahab N, Baccarelli A, Takser L.
    J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5157-5169. PubMed ID: 31058973
    [Abstract] [Full Text] [Related]

  • 13. Circulating extracellular vesicles exhibit a differential miRNA profile in gestational diabetes mellitus pregnancies.
    Thamotharan S, Ghosh S, James-Allan L, Lei MYY, Janzen C, Devaskar SU.
    PLoS One; 2022 Nov 01; 17(5):e0267564. PubMed ID: 35613088
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of candidate circulating microRNAs in maternal blood leukocytes of the patients with preeclampsia and gestational diabetes mellitus.
    Hocaoglu M, Demirer S, Senturk H, Turgut A, Komurcu-Bayrak E.
    Pregnancy Hypertens; 2019 Jul 01; 17():5-11. PubMed ID: 31487656
    [Abstract] [Full Text] [Related]

  • 15. Gestational diabetes and maternal obesity are associated with sex-specific changes in miRNA and target gene expression in the fetus.
    Joshi A, Azuma R, Akumuo R, Goetzl L, Pinney SE.
    Int J Obes (Lond); 2020 Jul 01; 44(7):1497-1507. PubMed ID: 31852997
    [Abstract] [Full Text] [Related]

  • 16. Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.
    Collares CV, Evangelista AF, Xavier DJ, Rassi DM, Arns T, Foss-Freitas MC, Foss MC, Puthier D, Sakamoto-Hojo ET, Passos GA, Donadi EA.
    BMC Res Notes; 2013 Nov 26; 6():491. PubMed ID: 24279768
    [Abstract] [Full Text] [Related]

  • 17. Systematic review of transcriptome and microRNAome associations with gestational diabetes mellitus.
    Lewis KA, Chang L, Cheung J, Aouizerat BE, Jelliffe-Pawlowski LL, McLemore MR, Piening B, Rand L, Ryckman KK, Flowers E.
    Front Endocrinol (Lausanne); 2022 Nov 26; 13():971354. PubMed ID: 36704034
    [Abstract] [Full Text] [Related]

  • 18. Extracellular vesicle-associated miRNAs are an adaptive response to gestational diabetes mellitus.
    Nair S, Guanzon D, Jayabalan N, Lai A, Scholz-Romero K, Kalita de Croft P, Ormazabal V, Palma C, Diaz E, McCarthy EA, Shub A, Miranda J, Gratacós E, Crispi F, Duncombe G, Lappas M, McIntyre HD, Rice G, Salomon C.
    J Transl Med; 2021 Aug 20; 19(1):360. PubMed ID: 34416903
    [Abstract] [Full Text] [Related]

  • 19. Early-Pregnancy Serum Maternal and Placenta-Derived Exosomes miRNAs Vary Based on Pancreatic β-Cell Function in GDM.
    Razo-Azamar M, Nambo-Venegas R, Quevedo IR, Juárez-Luna G, Salomon C, Guevara-Cruz M, Palacios-González B.
    J Clin Endocrinol Metab; 2024 May 17; 109(6):1526-1539. PubMed ID: 38127956
    [Abstract] [Full Text] [Related]

  • 20. Circulating microRNA (miRNA) Expression Profiling in Plasma of Patients with Gestational Diabetes Mellitus Reveals Upregulation of miRNA miR-330-3p.
    Sebastiani G, Guarino E, Grieco GE, Formichi C, Delli Poggi C, Ceccarelli E, Dotta F.
    Front Endocrinol (Lausanne); 2017 May 17; 8():345. PubMed ID: 29312141
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.